Global Hyaluronic Acid Injections Market US$ 11.5 Billion by 2021

Global Hyaluronic Acid Injections Market US$ 11.5 Billion by 2021

Hyaluronic acid is naturally present in the highest concentrations in fluids in the eyes and joints. The hyaluronic acid for medicine is either extracted from rooster combs or biologically synthesized in bacteria. Hyaluronic acid is used for various joint disorders, including osteoarthritis and during certain eye surgeries including cataract removal, corneal transplantation, and repair of a detached retina and other eye injuries. It is injected into the eye during the procedure to help replace natural fluids. It can be taken by mouth or injected into the affected joint.

According to a market research report Hyaluronic Acid Injections Market 2017-2021 published by iHealthcareAnalyst, Inc., the global hyaluronic acid injections market is estimated to reach US$ 10.5 Billion in 2020, expanding at a CAGR of 8.8% from 2017 to 2021.

Visit the Hyaluronic Acid Injections Market 2017-2021 report at https://www.ihealthcareanalyst.com/report/hyaluronic-acid-injections-market/

The global hyaluronic acid injections market segmentation is based on product types (single-injection cycle products, three-injection cycle products, five- injection cycle products), applications (osteoarthritis, ophthalmic, dermal fillers, vesicoureteral reflux). The global hyaluronic acid injections market report provides market size (Revenue US$ Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global hyaluronic acid injections market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Injection Type
1.1 Single-Injection Cycle
1.2 Three-Injection Cycle
1.3 Five- Injection Cycle

2. Applications
2.1 Osteoarthritis
2.2 Ophthalmic
2.3 Dermal Fillers
2.4 Vesicoureteral Reflux

3. Geography (Region, Country)
3.1 North America (U.S., Canada)
3.2 Latin America (Brazil, Mexico, Rest of LA)
3.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4 Asia Pacific (Japan, China, India, Rest of APAC)
3.5 Rest of the World

4. Company Profiles
4.1 Alcon, Inc.
4.2 Allergan, Inc.
4.3 Anika Therapeutics, Inc.
4.4 F.Hoffmann-La Roche Ltd.
4.5 Ferring Pharmaceuticals, Inc.
4.6 Fidia Farmaceutici SpA
4.7 Galderma S.A.
4.8 Hyaltecg Ltd.
4.9 LifeCore Biomedical LLC
4.10 Meiji Seika Pharma Co. Ltd.
4.11 Merz Aesthetics, Inc.
4.12 Sanofi
4.13 Salix Pharmaceuticals, Inc.
4.14 Seikagaku Corporation
4.15 Shanghai Jingfeng Pharmaceutical Co. Ltd.
4.16 Smith & Nephew plc
4.17 TRB Chemedica International Sa
4.18 Zimmer Holdings, Inc.

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

2017-11-05T09:54:33+00:00 Categories: Press Releases|